報價延遲最少15分鐘:2026/03/12 02:26 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
24.84 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-20.75/4.22
|
|
企業價值
2.69B
|
| 資產負債 |
|
每股賬面淨值
26.02
|
| 現金流量 |
|
現金流量率
0.16
|
| 損益表 |
|
收益
2.25B
|
|
每股收益
29.04
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recoverysegment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries. |
